H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.6% of adults in Fayetteville have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Census population 208,501. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fayetteville clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fayetteville storefront.
Sports Injury Biologic Treatments in Fayetteville, NC for clinics & physicians. Biologic treatments for sp… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Fayetteville is 40.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.6% of adults in Fayetteville have diagnosed diabetes — 0.6 points above the U.S. 12% figure. North Carolina includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for sports injury biologics, not a walk-in clinic.
National Sports Injury Biologic Treatments notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.6% of adults in Fayetteville have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Adult obesity in Fayetteville is 40.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 24.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JM / Palmetto GBA, sibling states SC, VA, WV. N.C. Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Fayetteville warehouse or a five-star local review. What you get is sports injury biologics from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JM, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.6% of adults — 0.6 points above the U.S. 12% figure. Obesity is 40.4%; arthritis is 24.9%. That is place-level BRFSS modeling, not a clinic census and not a Fayetteville trial.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including North Carolina.
North Carolina is JM. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Fayetteville tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fayetteville, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fayetteville is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fayetteville — 0.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fayetteville. Useful for joint-program math; still needs a diagnosis and privileging.
No Fayetteville storefront. Joe Bradley is an active practice owner. sports injury biologics stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.